SPHERA FUNDS MANAGEMENT LTD.: 13F holdings
CIK 14962012026Q2
| Positions | 101 |
|---|
| Reported value | $765.6m |
|---|
| Filed | 2026-08-14 |
|---|
Change since last quarter
| Positions | 101 (+6 vs prior quarter) |
|---|
| Reported value | $765.6m (+21.6%) |
|---|
Top 10 holdings
| Security | Shares | Value | Weight |
|---|
| TEVA PHARMACEUTICAL INDS LTD | 1,500,082 | $50.8m | 6.6% |
| MLYS MINERALYS THERAPEUTICS INC | 1,469,971 | $39.7m | 5.2% |
| TOWER SEMICONDUCTOR LTD | 108,265 | $28.2m | 3.7% |
| SNDX SYNDAX PHARMACEUTICALS INC | 1,014,606 | $22.2m | 2.9% |
| BIIB BIOGEN INC | 96,626 | $20.9m | 2.7% |
| RARE ULTRAGENYX PHARMACEUTICAL IN | 588,494 | $19.6m | 2.6% |
| BMRN BIOMARIN PHARMACEUTICAL INC | 328,550 | $18.8m | 2.5% |
| CYTK CYTOKINETICS INC | 219,987 | $18.7m | 2.4% |
| BBIO BRIDGEBIO PHARMA INC | 245,346 | $18.3m | 2.4% |
| COGT COGENT BIOSCIENCES INC | 459,340 | $17.8m | 2.3% |
Get the full book
import finzdata as yf
yf.Client().manager_holdings(cik="1496201")
Every position, quarter by quarter since 2013, with adds, trims and exits, on the look-back bundles.
Get a free API keySee history bundlesDownload free samples